The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review

Diabetes mellitus (DM) is one of the most common comorbidities among patients with coronavirus disease 2019 (COVID-19) which may exacerbate complications of this new viral infection. Metformin is an anti-hyperglycemic agent with host-directed immune-modulatory effects, which relieve exaggerated infl...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in endocrinology (Lausanne) Vol. 12; p. 645194
Main Authors:	Zangiabadian, Moein, Nejadghaderi, Seyed Aria, Zahmatkesh, Mohammad Mahdi, Hajikhani, Bahareh, Mirsaeidi, Mehdi, Nasiri, Mohammad Javad
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 19.03.2021
Subjects:	2019-nCoV COVID-19 COVID-19 - complications COVID-19 - drug therapy Diabetes Complications - drug therapy diabetes mellitus Diabetes Mellitus - drug therapy Endocrinology Humans Hypoglycemic Agents - therapeutic use metformin Metformin - therapeutic use SARS-CoV-2 systematic review COVID-19 metformin SARS-CoV-2 diabetes mellitus 2019-nCoV systematic review
ISSN:	1664-2392, 1664-2392
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!